IP Library › Granted Patent US 6,992,108
Granted Patent B1
US 6,992,108 · App. 08/482,737 · Granted Jan 31, 2006

Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

Assignees: The Salk Institute for Biological Studies; Baylor College of Medicine; Ligand Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,992,108
App. No.
08/482,737
Granted
Jan 31, 2006
Kind
B1
Abstract

A method for modulating lipid metabolism in a subject by administering 9-cis retinoic acid is presented. The 9-cis retinoic acid is more specific for the retinoid X receptor than is retinoic acid.

Claims (1)

1. A method to modulate lipid metabolism in a subject, said method comprising administering to said subject an effective amount of 9-cis-retinoic acid, or pharmaceutically acceptable carrier containing same.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2008
From: LIGAND PHARMACEUTICALS INCORPORATED; SERAGEN, INC.
To: EISAI INC.
Reel/Frame 021339/0344 →
Continuity (3)
Division 0824485700 · Jun 14, 1994
Continuation PCTUS921121400 · Dec 18, 1992
Continuation In Part 0780998000 · Dec 18, 1991